Ion Beam Applications

IBA is looking for 100 new collaborators in Belgium by June 2023

14 Mar 2023 08:00:00 By Nasdaq GlobeNewswire

CONVOCATION À UNE ASSEMBLÉE GÉNÉRALE EXTRAORDINAIRE D’IBA SA

09 Mar 2023 09:55:00 By Nasdaq GlobeNewswire

IBA - Regulated Information

25 Jan 2023 11:00:00 By Nasdaq GlobeNewswire

IBA announces contract with Moffitt Cancer Center for a Proteus®ONE proton therapy solution in Florida, US

10 Jan 2023 00:00:00 By Nasdaq GlobeNewswire

IBA signs contract to install a fully integrated X-ray irradiation solution in France   

22 Dec 2022 00:00:00 By Nasdaq GlobeNewswire

IBA Wins 10 Proton Therapy System Contract in Spain  

08 Dec 2022 00:00:00 By Nasdaq GlobeNewswire

IBA – Transparency Notification

07 Dec 2022 10:45:00 By Nasdaq GlobeNewswire

IBA - Regulated Information

28 Nov 2022 10:45:00 By Nasdaq GlobeNewswire

IBA Business Update – Third Quarter 2022

17 Nov 2022 00:00:00 By Nasdaq GlobeNewswire

IBA expands its activities in Sub-Saharan Africa and signs contract with Sweden Ghana Medical Centre for an IntegraLab® PLUS in Accra, Ghana

13 Oct 2022 00:00:00 By Nasdaq GlobeNewswire

ElsMed, Novatec and IBA sign contract to install radiopharmaceutical production center in Georgia

04 Oct 2022 00:00:00 By Nasdaq GlobeNewswire

IBA and SCK CEN launch Pantera, a joint-venture to produce actinium-225

22 Sep 2022 00:00:00 By Nasdaq GlobeNewswire

NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron® Electron Beam Accelerators for Commercial Production of Radioisotopes

20 Sep 2022 00:00:00 By Nasdaq GlobeNewswire

IBA Reports Half Year 2022 Results

31 Aug 2022 00:00:00 By Nasdaq GlobeNewswire

IBA and ScandiDos form strategic alliance to increase access to safe radiotherapy

30 Aug 2022 11:00:00 By Nasdaq GlobeNewswire

IBA qualifies as the only supplier for second round of tender to provide ten proton therapy units across Spain        

26 Aug 2022 00:00:00 By Nasdaq GlobeNewswire

IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy

02 Aug 2022 00:00:00 By Nasdaq GlobeNewswire

IBA signs contract with Istituto Clinico Humanitas for a Proteus®ONE proton therapy solution in Italy

30 Jun 2022 00:00:00 By Nasdaq GlobeNewswire

IBA signs Proteus®ONE contract with Baptist Health’s Lynn Cancer Institute for a new proton therapy center in South Florida, USA        

01 Jun 2022 00:00:00 By Nasdaq GlobeNewswire

IBA Business Update – First Quarter 2022

19 May 2022 00:00:00 By Nasdaq GlobeNewswire